Necrotizing skin and soft-tissue infections in the intensive care unit. | Canada Hyperbarics Skip to main content
Cochrane Review Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2020

Necrotizing skin and soft-tissue infections in the intensive care unit.

Peetermans M, de Prost N, Eckmann C, Norrby-Teglund A, Skrede S, De Waele JJ — Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a literature review using Medline and Cochrane library, supported by a multidisciplinary expert panel, to examine all aspects of care for critically ill patients with necrotizing skin and soft-tissue infections (NSTI).

What They Found

They found that prompt surgery with aggressive debridement and immediate broad-spectrum antimicrobial therapy, including clindamycin, are crucial for critically ill patients with necrotizing skin and soft-tissue infections (NSTI). The initial presentation can be misleading, and delayed surgery worsens prognosis, while the utility of clinical scores, immunoglobulins, and hyperbaric oxygen therapy remains controversial, with many aspects of management supported by low-quality data.

What This Means for Canadian Patients

Canadian patients with necrotizing skin and soft-tissue infections (NSTI) require rapid diagnosis and immediate, aggressive surgical debridement combined with broad-spectrum antibiotics to improve outcomes. Access to specialized multidisciplinary care, involving intensive care, surgery, microbiology, and infectious diseases, is vital for effective management of these severe infections.

Canadian Relevance

This study has no direct Canadian connection as it is a general review of international literature.

Study Limitations

A significant limitation is that many aspects of necrotizing skin and soft-tissue infection management are currently supported by low-quality data, highlighting the urgent need for multicentre trials.

Was this summary helpful?

Study Details

Study Type Cochrane Review
Category Infection
Source Pubmed
PubMed ID 31284035
Year Published 2020
Journal Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
MeSH Terms Anti-Bacterial Agents; Bacteria; Critical Illness; Debridement; Disease Management; Fasciitis, Necrotizing; Humans; Intensive Care Units; Skin; Soft Tissue Infections

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.